ICD-10-CM Billable Code

C92.20

Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission

Clinical Classification Guidelines

Inclusion Terms

  • Atypical chronic myeloid leukemia, BCR/ABL-negative with failed remission
  • Atypical chronic myeloid leukemia, BCR/ABL-negative NOS

Medical Intelligence & Overview

Atypical chronic myeloid leukemia (aCML), BCR/ABL-negative, is a rare type of blood cancer that affects the bone marrow and blood. Unlike classic chronic myeloid leukemia (CML), this form does not have the Philadelphia chromosome or the BCR/ABL gene mutation. It is characterized by the uncontrolled growth of abnormal myeloid cells, which can lead to symptoms such as fatigue, infections, and anemia. When diagnosed as not having achieved remission, it means that medical treatments have not successfully reduced or eliminated the cancer cells.

Causes & Symptoms

Clinical Causes: Genetic mutations — specific genetic changes may contribute to the development of aCML Environmental factors — exposure to certain chemicals or toxins might play a role Previous radiation therapy — history of radiation exposure could be a risk factor Unknown factors — in many cases, the exact cause remains unidentified

Key Symptoms: Fatigue or weakness Frequent infections Easy bruising or bleeding Night sweats Unintentional weight loss Enlarged spleen or liver Bone pain or tenderness Shortness of breath

Diagnostic & Treatment

Diagnosis Path: Diagnosis of atypical CML involves a combination of blood tests, bone marrow biopsy, and genetic studies. Key steps include:

Treatment Protocols: Treatment options for aCML that has not achieved remission may involve:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C92.20 a billable ICD-10 code?
Yes, C92.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C92.20?
Clinical documentation must specify the nature of Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

chronic atypical myeloid remission achieved